Fox Business - The Power to Prosper
Search Site

Baxter International

Related Topics

  1. Robert Half International
  2. Cameron International
  3. DaVita
  4. Marriott International
  5. Leap Wireless International
  6. Tyco International
Get updates on Baxter International
Baxter's Potential Alzheimer's Treatment Immunoglobulin Misses Primary Endpoints

Baxter International Inc. (BAX) said results from a late-stage study of its potential treatment for Alzheimer's, immunoglobulin, were negative.The results didn't meet the co-primary endpoints of reducing cognitive decline and preserving functional abilities in patients with mild to moderate Alzheimer's disease.Baxter--which makes medical products for people with bleeding, kidney and immune disorders, among other conditions--said it will reconsider its current approach for its Alzheimer's program and will determine next steps after full data analyses. Current Baxter studies of immunoglobulin in mild to moderate Alzheimer's disease will be discontinued.Top-line analyses from the randomized, double-blind, placebo-controlled, multicenter trial found that after 18 months of treatment, patients with mild to moderate Alzheimer's disease taking Baxter's immunoglobulin treatment didn't demonstrate a statistically significant difference in the rate of cognitive decline as compared with placebo. ...

Read More ›

  1. Cangene Wins Auction for Inspiration's Hemophilia Drug

    Inspiration Biopharmaceuticals Inc. reached a deal to sell its second development-stage hemophilia drug at auction Tuesday to Cangene Corp. for $5.9 million in cash ...

  2. Investor Raises Dividend as 4Q NAV/Share Rises 12% on Year

    Investor AB (INVE-B.SK), the Swedish investment company, Tuesday posted a 12% on-year rise in net asset value per share and raised its dividend, adding that it aims ...

  3. Eurozone PMI Beats Expectations, Points Toward Contraction

    FBN’s Diane Macedo breaks down the stories moving the markets around the world.

  4. Baxter International 4th-Quarter Net Up 6.7%; Gives Downbeat 1st-Quarter View

    Baxter International Inc. (BAX) posted a 6.7% rise in fourth-quarter earnings as the company's focus on life-saving therapies continued to drive sales.The medical-pr...

  5. Medical Device Tax Driving Companies Out of U.S.?

    Cyberonics CEO Daniel Moore on the impact of the medical device tax on jobs and patient care.

  6. Baxter's Investigational Hemophilia Treatment Yields Positive Results

    Baxter International Inc. (BAX) said results from a study evaluating its investigational treatment for patients with hemophilia B were positive.The medical product c...

  7. Baxter to buy Sweden's Gambro for $4 billion

    Healthcare products maker Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion t...

  8. MARKET SNAPSHOT: U.S. Stocks Retreat With Fiscal Cliff In View

    U.S. stock indexes fell modestly Tuesday as U.S. political leaders readied for more budgets talks to avert steep tax hikes and spending cuts that could push the econ...

  9. Baxter International Buys Gambro for $4B

    FOX Business brief: Late-morning markets

  10. UPDATE 2-Baxter to buy Sweden's Gambro for about $4 billion

    Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion to complement its kidney th...

  11. MARKET SNAPSHOT: U.S. Stock Indexes Stable On Fiscal-cliff View

    U.S. stock indexes were little changed Tuesday as U.S. political leaders readied for more budgets talks to avert steep tax hikes and spending cuts that could push th...

  12. Baxter to buy Sweden's Gambol for about $4 billion

    Baxter International Inc said on Tuesday that it would buy privately held Swedish dialysis product company Gambro AB for about $4 billion to complement its kidney th...

  1. Health-Care Companies Report Slowdown in Patient Visits

    The spike late last year in doctor and hospital visits apparently lasted as long as the flu.After years of decelerating health-care usage--linked to economic problem...

  2. Baxter's Sales Rise, But Health-Care Pressures Remain

    Baxter International Inc. (BAX) reported a slight increase in first-quarter sales, as growth in emerging markets helped to offset continued pricing and utilization p...

  3. Baxter 1st-Quarter Profit Off 11% on Acquisition-Related Charges

    Baxter International Inc.'s (BAX) first-quarter earnings fell 11% as the medical-products company was hurt by acquisition-related charges and the year-earlier period...

  4. Market Wrap for Friday, March 22: Stocks Rise on Hopes of Bailout Deal for Cyprus

    The U.S. stock market closed out a choppy week with a gain as policymakers in Cyprus were in talks with EU officials to secure a bailout for the Mediterranean island...

  5. Gentium Gets Negative Opinion From CHMP; Biogen, Others Get Positive Opinions

    Gentium SpA (GENT) said the European Medicines Agency's Committee for Medicinal Products for Human Use issued a negative opinion, recommending the refusal of marketi...

  6. Insight - A casualty of the financial crisis: The corporate palace

    In the past year, defense company SAIC Inc has shrunk the office space it either owns or leases by 306,000 square feet (28,428 sq meters), the size of about five foo...

  7. CSL Beats Expectations With 24% Increase in 1st Half Net Profit

    CSL Ltd. (CSL.AU), one of the world's biggest manufacturers of blood plasma and flu vaccines, said Wednesday its first half profit rose 24% as it capitalized on a ri...

‹ Prev12345Next ›
Freebase CC-BY
Source: Baxter International on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL